Neumora Therapeutics (NMRA) Total Debt (2025 - 2026)

Neumora Therapeutics' Total Debt history runs 2 years deep, the most recent figure standing at $53.0 million for Q1 2026.

• In Q1 2026, Total Debt changed N/A year-over-year to $53.0 million; the TTM figure through Mar 2026 stood at $53.0 million (changed N/A YoY), while the FY2025 annual figure was $54.5 million, changed N/A from the prior year.
• Total Debt for Q1 2026 stood at $53.0 million, down from $54.5 million in the prior quarter.
• The five-year high for Total Debt was $54.5 million in Q4 2025, with the low at $19.5 million in Q2 2025.